Home Sectors Healthcare Current Technicals: Prestige Consumer Healthcare (NYSE: PBH)

Current Technicals: Prestige Consumer Healthcare (NYSE: PBH)


Prestige Consumer Healthcare trades as part of the healthcare sector and medical distribution industry. The company CEO is Ronald Lombardi. Prestige Brands Inc is a healthcare company. Its core business involves the distribution of healthcare and household cleaning products to supermarkets and drug stores.

Previous Intraday Trading Performance:

The PBH stock showed a previous change of 3.44% with an open at 29.75 and a close of 30.70. It reached an intraday high of 30.84 and a low of 29.64.

SeekingAlpha:  Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2019 Results – Earnings Call Transcript


The stock has a market cap of $1.6b with 51.8m shares outstanding, of which the float is 49.2m shares. Trading volume reached 556,750 shares compared to its average volume of 413,424 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, Prestige Consumer Healthcare shares returned 4.92% and in the past 30 trading days it returned 7.49%. Over three months, it changed 7.19%. In one year it has changed -9.86% and within that year its 52-week high was 41.76 and its 52-week low was 26.25. PBH stock is 16.95% above its 52 Week Low.

Our calculations show a 200 day moving average of 32.83 and a 50 day moving average of 29.30. Currently PBH stock is trading -6.50% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.

SeekingAlpha:  Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2019 Results – Earnings Call Transcript


The last annual fiscal EPS for the company was reported at -0.69 that ended on 31st of March 2019. Based on 4 analyst estimates, the consensus EPS for the next quarter is 0.66. The TTM EPS is 2.61, which comes to a TTM PE of 11.76.

Below was the last reported quarterly diluted earnings per share:

1stQtr of 2019 (Reported on 05/09/2019): -2.68
4thQtr of 2018 (Reported on 02/07/2019): 0.73
3rdQtr of 2018 (Reported on 11/01/2018): 0.59
2ndQtr of 2018 (Reported on 08/02/2018): 0.65
1stQtr of 2018 (Reported on 05/10/2018): -0.75

Base on our calculations, the intrinsic value per share is 48.65, which means it is possibly undervalued and has a margin of safety of 36.89%.

Indicators to Watch:

Short-interest was 10,726,851, which was 20.71% of shares outstanding. The short-interest ratio or days-to-cover ratio was 17.89. This stock has a high level of short interest and may fall in value in the near term.

The current calculated beta is 0.90.

SeekingAlpha:  Tech Data EPS beats by $0.07, misses on revenue

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is -3.30%, return on assets is -1.04%, profit margin is -3.85%, price-to-sales is 1.58 and price-to-book is 1.40.

Company Scores:

All scores are out of six:
 2  :Valuation Score
 0  :Past Performance Score
 2  :Financial Strength Score
 3  :Future Growth Score
 0  :Dividend Score
 1  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.